Cargando…
Human T leukaemia Type 1 and COVID-19
In the absence of clinical data on Human T leukaemia Type 1 and COVID-19 infection, we are providing guidance to clinicians who look after people living with HTLV-1.
Autores principales: | Araujo, Abelardo, Martin, Fabiola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350292/ https://www.ncbi.nlm.nih.gov/pubmed/32503140 http://dx.doi.org/10.3390/pathogens9060438 |
Ejemplares similares
-
Leukæmia and Pseudo-Leukæmia
Publicado: (1877) -
Human T-cell leukaemia virus type 1 and Adult T-cell leukaemia/lymphoma in Queensland, Australia: a retrospective cross-sectional study
por: Martin, Fabiola, et al.
Publicado: (2023) -
Targeted Therapy in Leukaemia, Lymphoma and Myeloma
por: Opat, Stephen Samuel
Publicado: (2022) -
Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022) -
Human T-cell leukaemia virus type 1: parasitism and pathogenesis
por: Bangham, Charles R. M., et al.
Publicado: (2017)